Scarica l'app Stockscreener
17.44
16.73%
2.50
Dopo l'orario di chiusura:
17.94
0.50
+2.87%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ATRA Giù?
Forum
Previsione
Atara Biotherapeutics Inc Borsa (ATRA) Ultime notizie
Is Atara Biotherapeutics Inc. stock safe for conservative investorsProfit Target & Low Risk High Reward Ideas - ulpravda.ru
Why Atara Biotherapeutics Inc. stock attracts global investorsEarnings Trend Report & Risk Controlled Swing Alerts - ulpravda.ru
Why Atara Biotherapeutics Inc. stock is a value investor pickWeekly Trading Summary & Low Risk High Win Rate Picks - ulpravda.ru
Atara Stock Plunges To 3-Month Low After FDA Blocks Blood Cancer Drug: Retail's Buying The Dip - MSN
Why Atara Biotherapeutics Inc. stock could be next big winnerQuarterly Market Summary & Daily Entry Point Trade Alerts - ulpravda.ru
Atara Biotherapeutics prices $16M public offering - MSN
Atara Biotherapeutics Stock (ATRA) Jumps as FDA Decision on Viral Therapy Nears - TipRanks
How Atara Biotherapeutics Inc. stock performs in interest rate cyclesMarket Volume Summary & Fast Moving Stock Trade Plans - ulpravda.ru
Atara revises tab-cel commercialization milestones with Pierre Fabre - MSN
What drives Atara Biotherapeutics Inc stock priceBearish Engulfing Patterns & Build Balanced Portfolio - earlytimes.in
(ATRA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Atara Biotherapeutics IncEntered fourth amendment with Pierre FabreSEC filing - marketscreener.com
Weekly Analysts’ Ratings Changes for Atara Biotherapeutics (ATRA) - Defense World
How Atara Biotherapeutics Inc. stock performs in stagflationHead and Shoulders Patterns & Easy Tools to Analyze Your Investment Risk - bollywoodhelpline.com
Technical Reactions to ATRA Trends in Macro Strategies - Stock Traders Daily
Biotech Stocks Facing FDA Decision In January 2026 - RTTNews
Can Atara Biotherapeutics Inc. stock deliver consistent earnings growthShort Interest Overview & Superior Trading Portfolio - bollywoodhelpline.com
Atara Biotherapeutics (ATRA) Price Target Increased by 15.69% to 20.06 - Nasdaq
Aug Outlook: Is Atara Biotherapeutics Inc. stock a good choice for value investors2025 Volume Leaders & AI Powered Market Trend Analysis - Улправда
Hedge Fund Bets: Can Atara Biotherapeutics Inc. stock deliver consistent earnings growthInsider Buying & Accurate Buy Signal Alerts - Улправда
Atara Biotherapeutics Earnings Notes - Trefis
Atara Biotherapeutics (ATRA) Sees Price Target Increase by Canac - GuruFocus
Is Atara Biotherapeutics Inc. (AT20) stock worth holding before Fed meetingEarnings Beat & Reliable Breakout Forecasts - Улправда
Can Atara Biotherapeutics Inc. stock surprise with earnings upsideJuly 2025 Drop Watch & Low Risk High Reward Trade Ideas - DonanımHaber
Is Atara Biotherapeutics Inc. stock a good choice for value investorsJuly 2025 Retail & Real-Time Volume Analysis Alerts - Улправда
(ATRA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Is Atara's Tab-Cel The Missing Piece In A Difficult-To-Treat Cancer? - RTTNews
Panic Selling: Why Atara Biotherapeutics Inc stock could be next big winner2025 Buyback Activity & Fast Momentum Stock Entry Tips - moha.gov.vn
Atara Biotherapeutics price target raised to $140 from $131 at Mizuho - MSN
With Atara Biotherapeutics Stock Surging, Have You Considered The Downside? - Trefis
Would You Still Hold Atara Biotherapeutics Stock If It Fell Another 30%? - Trefis
Can Atara Biotherapeutics Stock Recover If Markets Fall? - Trefis
How Atara Biotherapeutics Inc. stock performs during Fed tightening cyclesWeekly Investment Report & Weekly Watchlist of Top Performers - Newser
Can Atara Biotherapeutics Inc. (AT20) stock hit consensus price targetsJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - Newser
Is Atara Biotherapeutics Inc. (AT20) stock trading at attractive multiplesJuly 2025 Catalysts & Scalable Portfolio Growth Ideas - Newser
Why Atara Biotherapeutics Inc. (AT20) stock gets analyst attentionPortfolio Gains Summary & Daily Growth Stock Investment Tips - Newser
Is Confidence Futuristic Energetech Limited a Top Alpha Generator for Growth PortfoliosMarket Correction Analysis & Free Real-Time Trading Signals - earlytimes.in
Can Atara Biotherapeutics Inc. stock maintain operating margins2025 Key Lessons & Reliable Breakout Forecasts - Newser
Atara Biotherapeutics (ATRA) Stock Analysis Report | Financials & Insights - Benzinga
Atara Biotherapeutics (NASDAQ:ATRA) Stock Price Passes Below 50 Day Moving AverageHere's Why - MarketBeat
Why Atara Biotherapeutics Inc. (AT20) stock could rally strongly2025 Major Catalysts & Breakout Confirmation Trade Signals - Newser
How robust is Atara Biotherapeutics Inc. (AT20) stock financial positionPortfolio Growth Summary & Accurate Entry and Exit Point Alerts - Newser
Why analysts remain bullish on Atara Biotherapeutics Inc. stockTrade Analysis Report & Expert Curated Trade Setup Alerts - Newser
Can Atara Biotherapeutics Inc. (AT20) stock sustain revenue momentum2025 Trading Recap & Free Long-Term Investment Growth Plans - Newser
Is Atara Biotherapeutics Inc. stock attractive for long term wealth buildingQuarterly Risk Review & Expert Verified Movement Alerts - Newser
Will Atara Biotherapeutics Inc. (AT20) stock benefit from infrastructure billJuly 2025 PostEarnings & Verified Short-Term Plans - Newser
Atara Biotherapeutics: An Empty Pipeline With Little Gas (NASDAQ:ATRA) - Seeking Alpha
Pierre Fabre Pharmaceuticals Announces Transfer from Atara Biotherapeutics of the Biologics License Application (BLA) for Tabelecleucel as Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) (PR Newswire) - Aktiellt
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):